Nanotechnology-enabled immunoengineering approaches to advance therapeutic applications

Area of Science:

• Immunology and Nanotechnology
• Biomedical Engineering
• Translational Medicine

Background:

• Immunotherapy, including checkpoint blockade and CAR T-cell therapy, has shown significant clinical success.
• Current immunotherapies face challenges such as off-target effects, systemic toxicities, and suboptimal efficacy.
• The immune system's role in various diseases beyond cancer is increasingly recognized.

Purpose of the Study:

• To explore how nanoscale engineering can improve existing immunotherapies.
• To leverage nanomaterials for precise manipulation of immune cell functions.
• To develop novel nanoengineering strategies for treating diverse pathologies.

Main Methods:

• Utilizing nanomaterials with tunable properties (size, shape, charge, surface chemistry).
• Targeting and engineering specific immune cells like dendritic cells and T cells.
• Delivering small molecule drugs or biologics via nano-scaffolds.

Main Results:

• Nanoscale engineering enables enhanced immunity against cancers and pathogens.
• Strategies for controlling immune response sites and promoting tolerance are developed.
• Tailoring nanomaterial properties allows for specific immune cell targeting and functional modulation.

Conclusions:

• Nanoscale engineering offers a powerful platform to overcome limitations in current immunotherapy.
• Harnessing immune cell activities through nanoengineering holds promise for treating injuries and diseases.
• This approach can lead to more effective and safer therapeutic interventions.